Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 32Unknown 13Terminated 13Recruiting 13Not yet recruiting 5Active not recruiting 4Available 2Suspended 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 28Pancreatic Neoplasms 17Stomach Neoplasms 13Carcinoma, Hepatocellular 13Breast Neoplasms 8Rectal Neoplasms 7Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Cholangiocarcinoma 4Neoplasm Metastasis 3Lung Neoplasms 3Endometrial Neoplasms 3Diabetes Mellitus 3Crohn Disease 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Multiple Sclerosis 2Multiple Myeloma 2Melanoma 2Liver Neoplasms 2Irritable Bowel Syndrome 2Head and Neck Neoplasms 2Gastrointestinal Stromal Tumors 2Gastrointestinal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Squamous Cell × Gastrointestinal × Clear all
NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡